BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17235239)

  • 1. Birth outcome in Danish women with cutaneous malignant melanoma.
    Langagergaard V; Puho EH; Lash TL; Nørgård B; Sørensen HT
    Melanoma Res; 2007 Feb; 17(1):31-6. PubMed ID: 17235239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive history and cutaneous malignant melanoma: a comparison between women and men.
    Kaae J; Andersen A; Boyd HA; Wohlfahrt J; Melbye M
    Am J Epidemiol; 2007 Jun; 165(11):1265-70. PubMed ID: 17327217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes.
    Rebordosa C; Kogevinas M; Bech BH; Sørensen HT; Olsen J
    Int J Epidemiol; 2009 Jun; 38(3):706-14. PubMed ID: 19332503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study.
    Nørgård B; Fonager K; Sørensen HT; Olsen J
    Am J Gastroenterol; 2000 Nov; 95(11):3165-70. PubMed ID: 11095336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal risk factors for cutaneous malignant melanoma: follow-up of 2,594,783 Danes born from 1950 to 2002.
    Olesen AV; Parner ET; Mortensen PB; Sørensen HT; Olsen J
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):155-61. PubMed ID: 19124493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma: reduced risk associated with early childbearing and multiparity.
    Lambe M; Thörn M; Sparén P; Bergström R; Adami HO
    Melanoma Res; 1996 Apr; 6(2):147-53. PubMed ID: 8791273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
    Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
    Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy history and incidence of melanoma in women: a pooled analysis.
    Karagas MR; Zens MS; Stukel TA; Swerdlow AJ; Rosso S; Osterlind A; Mack T; Kirkpatrick C; Holly EA; Green A; Gallagher R; Elwood JM; Armstrong BK
    Cancer Causes Control; 2006 Feb; 17(1):11-9. PubMed ID: 16411048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    Nørgård B; Pedersen L; Christensen LA; Sørensen HT
    Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma in pregnancy. A population-based evaluation.
    O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
    Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcomes of pregnancy-associated melanoma in New South Wales 1994-2008.
    Bannister-Tyrrell M; Roberts CL; Hasovits C; Nippita T; Ford JB
    Aust N Z J Obstet Gynaecol; 2015 Apr; 55(2):116-22. PubMed ID: 25349945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.
    Kroman N; Jensen MB; Wohlfahrt J; Ejlertsen B;
    Acta Oncol; 2008; 47(4):545-9. PubMed ID: 18465320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stillbirth recurrence in a population of relatively low-risk mothers.
    Sharma PP; Salihu HM; Kirby RS
    Paediatr Perinat Epidemiol; 2007 Jul; 21 Suppl 1():24-30. PubMed ID: 17593194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.
    Wogelius P; Nørgaard M; Gislum M; Pedersen L; Schønheyder HC; Sørensen HT
    Int J Antimicrob Agents; 2005 Oct; 26(4):323-6. PubMed ID: 16144758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohort.
    Howitz MF; Simonsen J; Krause TG; Robbins JB; Schneerson R; Mølbak K; Miller MA
    Pediatr Infect Dis J; 2009 Mar; 28(3):199-203. PubMed ID: 19165135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
    Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: a population-based study.
    Lei U; Wohlfahrt J; Christens P; Westergaard T; Lambe M; Nørgaard-Pedersen B; Melbye M
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1147-51. PubMed ID: 15548147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study.
    Ratanajamit C; Skriver MV; Nørgaard M; Jepsen P; Schønheyder HC; Sørensen HT
    J Antimicrob Chemother; 2003 Nov; 52(5):837-41. PubMed ID: 14519675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark.
    Ulff-Møller CJ; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    J Rheumatol; 2009 Sep; 36(9):1903-9. PubMed ID: 19567628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.